Abstract

Accumulation of somatic mutations in the mitochondrial genome (mtDNA) has long been proposed as a possible mechanism of mitochondrial and tissue dysfunction that occurs during aging. A thorough characterization of age-associated mtDNA somatic mutations has been hampered by the limited ability to detect low frequency mutations. Here, we used Duplex Sequencing on eight tissues of an aged mouse cohort to detect >89,000 independent somatic mtDNA mutations and show significant tissue-specific increases during aging across all tissues examined which did not correlate with mitochondrial content and tissue function. G→A/C→T substitutions, indicative of replication errors and/or cytidine deamination, were the predominant mutation type across all tissues and increased with age, whereas G→T/C→A substitutions, indicative of oxidative damage, were the second most common mutation type, but did not increase with age regardless of tissue. We also show that clonal expansions of mtDNA mutations with age is tissue and mutation type dependent. Unexpectedly, mutations associated with oxidative damage rarely formed clones in any tissue and were significantly reduced in the hearts and kidneys of aged mice treated at late age with Elamipretide or nicotinamide mononucleotide. Thus, the lack of accumulation of oxidative damage-linked mutations with age suggests a life-long dynamic clearance of either the oxidative lesions or mtDNA genomes harboring oxidative damage.

Data availability

The Duplex-Seq-Pipeline is written in Python and R, but has dependencies written in other languages. The DuplexSeq-Pipeline software has been tested to run on Linux, Windows WSL1, Windows WSL2 and Apple OSX. The software can be obtained at https://github.com/KennedyLab-UW/Duplex-Seq-Pipeline. Raw mouse sequencing data used in this study are available at SRA accension PRJNA727407. The data from Arbeithuber et al. are available at SRA accension PRJNA563921. The final post-processed data, including variant call files, depth information, data summaries, and mutation frequencies, as well as the scripts to perform reproducible production of statistics and figure generation (with the exception of Figure 5C-E) are available at https://github.com/Kennedy-Lab-UW/Sanchez_Contreras_etal_2022.

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Monica Sanchez-Contreras

    Department of Laboratory Medicine and Pathology, University of Washington, Seattle, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3092-2781
  2. Mariya T Sweetwyne

    Department of Laboratory Medicine and Pathology, University of Washington, Seattle, United States
    For correspondence
    sandu@uw.edu
    Competing interests
    No competing interests declared.
  3. Kristine A Tsantilas

    Department of Biochemistry, University of Washington, Seattle, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4274-6930
  4. Jeremy A Whitson

    Department of Laboratory Medicine and Pathology, University of Washington, Seattle, United States
    Competing interests
    No competing interests declared.
  5. Matthew D Campbell

    Department of Radiology, University of Washington, Seattle, United States
    Competing interests
    No competing interests declared.
  6. Brenden F Kohrn

    Department of Laboratory Medicine and Pathology, University of Washington, Seattle, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9948-2131
  7. Hyeon Jeong Kim

    Department of Biology, University of Washington, Seattle, United States
    Competing interests
    No competing interests declared.
  8. Michael J Hipp

    Department of Laboratory Medicine and Pathology, University of Washington, Seattle, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1904-0670
  9. Jeanne Fredrickson

    Department of Laboratory Medicine and Pathology, University of Washington, Seattle, United States
    Competing interests
    No competing interests declared.
  10. Megan M Nguyen

    Department of Laboratory Medicine and Pathology, University of Washington, Seattle, United States
    Competing interests
    No competing interests declared.
  11. James B Hurley

    Department of Biochemistry, University of Washington, Seattle, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7754-0705
  12. David J Marcinek

    Department of Radiology, University of Washington, Seattle, United States
    Competing interests
    No competing interests declared.
  13. Peter S Rabinovitch

    Department of Laboratory Medicine and Pathology, University of Washington, Seattle, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7169-3543
  14. Scott R Kennedy

    Department of Laboratory Medicine and Pathology, University of Washington, Seattle, United States
    For correspondence
    scottrk@uw.edu
    Competing interests
    Scott R Kennedy, is an equity holder and paid consultant for Twinstrand Biosciences, a for-profit company commercializing Duplex Sequencing. No Twinstrand products were used in the generation of the data..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4444-1145

Funding

National Institute on Aging (P01AG001751)

  • David J Marcinek
  • Peter S Rabinovitch

National Institute on Aging (K01AG062757)

  • Mariya T Sweetwyne

National Institute of Diabetes and Digestive and Kidney Diseases (R21DK128540)

  • Monica Sanchez-Contreras
  • Mariya T Sweetwyne

Congressionally Directed Medical Research Programs (W81XWH-16-1-0579)

  • Scott R Kennedy

National Human Genome Research Institute (R21HG011229)

  • Scott R Kennedy

National Cancer Institute (R21CA259780)

  • Scott R Kennedy

National Institute on Aging (T32AG000057)

  • Kristine A Tsantilas
  • Jeremy A Whitson

National Institute on Aging (T32AG066574)

  • Kristine A Tsantilas

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: This study was performed in accordance to the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to an approved institutional animal care and use committee (IACUC) protocol (2174-23) at the University of Washington.

Copyright

© 2023, Sanchez-Contreras et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,556
    views
  • 399
    downloads
  • 45
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Monica Sanchez-Contreras
  2. Mariya T Sweetwyne
  3. Kristine A Tsantilas
  4. Jeremy A Whitson
  5. Matthew D Campbell
  6. Brenden F Kohrn
  7. Hyeon Jeong Kim
  8. Michael J Hipp
  9. Jeanne Fredrickson
  10. Megan M Nguyen
  11. James B Hurley
  12. David J Marcinek
  13. Peter S Rabinovitch
  14. Scott R Kennedy
(2023)
The multi-tissue landscape of somatic mtdna mutations indicates tissue specific accumulation and removal in aging
eLife 12:e83395.
https://doi.org/10.7554/eLife.83395

Share this article

https://doi.org/10.7554/eLife.83395

Further reading

    1. Genetics and Genomics
    2. Microbiology and Infectious Disease
    Iti Mehta, Jacob B Hogins ... Larry Reitzer
    Research Article

    Polyamines are biologically ubiquitous cations that bind to nucleic acids, ribosomes, and phospholipids and, thereby, modulate numerous processes, including surface motility in Escherichia coli. We characterized the metabolic pathways that contribute to polyamine-dependent control of surface motility in the commonly used strain W3110 and the transcriptome of a mutant lacking a putrescine synthetic pathway that was required for surface motility. Genetic analysis showed that surface motility required type 1 pili, the simultaneous presence of two independent putrescine anabolic pathways, and modulation by putrescine transport and catabolism. An immunological assay for FimA—the major pili subunit, reverse transcription quantitative PCR of fimA, and transmission electron microscopy confirmed that pili synthesis required putrescine. Comparative RNAseq analysis of a wild type and ΔspeB mutant which exhibits impaired pili synthesis showed that the latter had fewer transcripts for pili structural genes and for fimB which codes for the phase variation recombinase that orients the fim operon promoter in the ON phase, although loss of speB did not affect the promoter orientation. Results from the RNAseq analysis also suggested (a) changes in transcripts for several transcription factor genes that affect fim operon expression, (b) compensatory mechanisms for low putrescine which implies a putrescine homeostatic network, and (c) decreased transcripts of genes for oxidative energy metabolism and iron transport which a previous genetic analysis suggests may be sufficient to account for the pili defect in putrescine synthesis mutants. We conclude that pili synthesis requires putrescine and putrescine concentration is controlled by a complex homeostatic network that includes the genes of oxidative energy metabolism.

    1. Genetics and Genomics
    Yi Li, Long Gong ... Shangbang Gao
    Research Article

    Resistance to anthelmintics, particularly the macrocyclic lactone ivermectin (IVM), presents a substantial global challenge for parasite control. We found that the functional loss of an evolutionarily conserved E3 ubiquitin ligase, UBR-1, leads to IVM resistance in Caenorhabditis elegans. Multiple IVM-inhibiting activities, including viability, body size, pharyngeal pumping, and locomotion, were significantly ameliorated in various ubr-1 mutants. Interestingly, exogenous application of glutamate induces IVM resistance in wild-type animals. The sensitivity of all IVM-affected phenotypes of ubr-1 is restored by eliminating proteins associated with glutamate metabolism or signaling: GOT-1, a transaminase that converts aspartate to glutamate, and EAT-4, a vesicular glutamate transporter. We demonstrated that IVM-targeted GluCls (glutamate-gated chloride channels) are downregulated and that the IVM-mediated inhibition of serotonin-activated pharynx Ca2+ activity is diminished in ubr-1. Additionally, enhancing glutamate uptake in ubr-1 mutants through ceftriaxone completely restored their IVM sensitivity. Therefore, UBR-1 deficiency-mediated aberrant glutamate signaling leads to ivermectin resistance in C. elegans.